Standout Papers

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Ca... 2005 2026 2012 2019 570
  1. Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale (2005)
    Giuseppe Colucci, Vittorio Gebbia et al. Journal of Clinical Oncology

Immediate Impact

69 standout
Sub-graph 1 of 23

Citing Papers

Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
2024 Standout
Augmenting Cancer Therapy with a Supramolecular Immunogenic Cell Death Inducer: A Lysosome-Targeted NIR-Light-Activated Ruthenium(II) Metallacycle
2024 Standout
2 intermediate papers

Works of A. Misino being referenced

Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale
2005 Standout

Author Peers

Author Last Decade Papers Cites
A. Misino 735 357 131 217 25 955
Valerie Poulart 673 279 113 251 17 1.0k
G Paoletti 757 342 149 227 28 944
L. Leong 645 234 236 186 39 1.0k
Daniel Rauch 665 371 218 154 52 1.0k
Seta Shahin 794 315 102 183 13 925
H.‐G. Mergenthaler 535 206 103 133 33 891
Tarek Chidiac 783 378 95 184 16 985
C.G. Alexopoulos 404 209 120 116 33 761
Joseph R. Bateman 535 184 163 182 36 972
S. Heeger 877 391 186 216 32 1.2k

All Works

Loading papers...

Rankless by CCL
2026